Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Vaxart Inc (VXRT)

Vaxart Inc (VXRT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 897,641
  • Shares Outstanding, K 109,202
  • Annual Sales, $ 9,860 K
  • Annual Income, $ -18,650 K
  • 60-Month Beta -0.04
  • Price/Sales 88.36
  • Price/Cash Flow N/A
  • Price/Book 21.64

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.09
  • Number of Estimates 3
  • High Estimate -0.06
  • Low Estimate -0.11
  • Prior Year -0.32
  • Growth Rate Est. (year over year) +71.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.51 +82.26%
on 09/02/20
9.52 -13.66%
on 08/19/20
-1.28 (-13.52%)
since 08/18/20
3-Month
2.51 +227.49%
on 06/22/20
17.49 -53.00%
on 07/14/20
+5.65 (+219.84%)
since 06/18/20
52-Week
0.25 +3,132.40%
on 09/25/19
17.49 -53.00%
on 07/14/20
+7.58 (+1,184.38%)
since 09/18/19

Most Recent Stories

More News
LAWSUITS FILED AGAINST NSP, VXRT and BLNK - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / September 18, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...

NSP : 67.92 (-1.37%)
VXRT : 8.22 (+3.01%)
BLNK : 8.39 (+10.25%)
Vaxart (VXRT) Surges: Stock Moves 8.1% Higher

Vaxart (VXRT) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

CTLT : 84.87 (+0.76%)
VXRT : 8.22 (+3.01%)
Lawsuits Filed Against VEL, COG and VXRT - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / September 17, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...

VEL : 5.37 (-1.10%)
COG : 19.39 (-0.10%)
VXRT : 8.22 (+3.01%)
Global UV Infection Control Device Market Could Exceed US$ 640 Million By 2026

, /PRNewswire/ -- In the present global health crisis, UV Light technology can be an important part of the infection control protocols that address infection prevention in the healthcare, hospitality,...

AUVI : 6.20 (+0.16%)
INO : 17.00 (+8.49%)
HTBX : 1.4050 (+1.08%)
VXRT : 8.22 (+3.01%)
MRNA : 69.87 (+2.92%)
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of FE, AEP and VXRT

NEW YORK, NY / ACCESSWIRE / September 17, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies....

FE : 28.96 (-2.82%)
AEP : 78.78 (-1.57%)
VXRT : 8.22 (+3.01%)
LAWSUITS FILED AGAINST FE, AEP and VXRT - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / September 16, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...

FE : 28.96 (-2.82%)
AEP : 78.78 (-1.57%)
VXRT : 8.22 (+3.01%)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Qutoutiao, Vaxart, Anaplan, and Blink Charging and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Qutoutiao, Inc. (NASDAQ: QTT), Vaxart,...

QTT : 2.47 (+2.07%)
VXRT : 8.22 (+3.01%)
PLAN : 58.07 (+0.68%)
BLNK : 8.39 (+10.25%)
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of NSP, VXRT and COTY

NEW YORK, NY / ACCESSWIRE / September 16, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate...

NSP : 67.92 (-1.37%)
VXRT : 8.22 (+3.01%)
COTY : 3.05 (-5.28%)
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of VXRT, POR and LX

NEW YORK, NY / ACCESSWIRE / September 16, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies....

VXRT : 8.22 (+3.01%)
POR : 34.99 (-1.02%)
LX : 6.84 (-0.87%)
DEADLINE ALERT for OSPN, VXRT, PLAN, and BLNK: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed...

OSPN : 22.70 (+7.18%)
VXRT : 8.22 (+3.01%)
PLAN : 58.07 (+0.68%)
BLNK : 8.39 (+10.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade VXRT with:

Business Summary

Vaxart, Inc. is a clinical-stage company developing a range of oral recombinant vaccines based on its proprietary delivery platform. The company's vaccines are administered using convenient room temperature-stable tablets that can be stored and shipped without refrigeration and eliminate risk of needle-stick...

See More

Key Turning Points

2nd Resistance Point 8.90
1st Resistance Point 8.56
Last Price 8.22
1st Support Level 7.75
2nd Support Level 7.28

See More

52-Week High 17.49
Fibonacci 61.8% 10.91
Fibonacci 50% 8.87
Last Price 8.22
Fibonacci 38.2% 6.84
52-Week Low 0.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar